Dr. Arsal Tharwani | Pulmonary Disease -Interstitial Lung Disease | Best Researcher Award

Fellow in Pulmonary and Critical Care at Cleveland Clinic, United States

Arsal Hassan Ali Tharwani is an emerging clinician and researcher specializing in pulmonary and critical care medicine. Having established a strong foundation in internal medicine, he has consistently demonstrated excellence both academically and clinically. Currently pursuing a Pulmonary Critical Care Fellowship at the prestigious Cleveland Clinic Foundation, he is recognized for his contributions to medical research and patient care. Through his dedication, leadership, and scholarly activities, Dr. Tharwani has earned multiple accolades, positioning himself as a promising figure in the field of pulmonary and critical care medicine.

Profile

Scopus

Education

Dr. Tharwani completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) from The Aga Khan University, Karachi, Pakistan, between 2014 and 2019, where he consistently ranked among the top students and received multiple academic scholarships and honors. Following his undergraduate training, he pursued an Internal Medicine Residency at the Cleveland Clinic Foundation from 2020 to 2023, during which he also earned several awards recognizing his clinical and research excellence. In 2023, he commenced his Pulmonary Critical Care Fellowship at the Cleveland Clinic Foundation. Additionally, he holds licensure from the State of Ohio, valid through August 2026, and earned his ECFMG certification in January 2021.

Experience

Throughout his career, Dr. Tharwani has cultivated a dynamic professional journey marked by his commitment to clinical excellence, teaching, and research. During his residency at Cleveland Clinic, he was honored multiple times as Inpatient Resident and Fellow of the Month, reflecting his outstanding clinical reasoning and teaching abilities. He actively participated in moderating national conferences such as CHEST and contributed to peer-reviewed journal activities. His leadership experiences extend back to his medical school days, where he organized major research forums and dramatics competitions, showcasing his ability to lead and inspire teams across diverse fields.

Research Interest

Dr. Tharwani’s research interests lie primarily in pulmonary diseases, critical care interventions, and cardiovascular complications associated with chronic illnesses. He has a particular focus on conditions such as pulmonary hypertension, interstitial lung disease (ILD), and sarcoidosis. His work often bridges clinical outcomes and research, emphasizing diagnostic innovations and therapeutic interventions that enhance patient management. His engagement in clinical trials and observational studies demonstrates a sustained commitment to advancing knowledge and improving clinical practices in pulmonary medicine and critical care.

Award

Dr. Tharwani’s exemplary research has earned him several prestigious awards. He was accepted into the Clinical Scholars Track in 2022, awarded based on the quality of his self-initiated research proposal. He won the Cleveland Clinic IMRP Research Award twice in consecutive years, 2022 and 2023, and delivered Grand Rounds Presentations recognized among the top research submissions. Additionally, he was awarded the Best Case Report Presentation by the American College of Chest Physicians in 2022. His clinical performance has been equally distinguished, receiving multiple Caregiver Appreciation Awards for collaboration, outstanding care, and patient advocacy, along with Resident and Fellow of the Month honors during his training.

Publication

Dr. Tharwani has contributed significantly to scientific literature, publishing research in reputable journals. Among his notable publications are: “A species dependent response to the pro-epileptic drug pentylenetetrazole in birds” (published in 2017, cited by 4 articles); “Bilateral psoas abscess after extracorporeal shockwave lithotripsy: Reminder of a rare complication” (published in 2018, cited by 3 articles); “Comparing the post-operative complications in pediatric patients undergoing cardiovascular procedures at a single institute” (published in 2019, cited by 2 articles); “Cardiovascular safety reporting in Contemporary Breast Cancer Trials” (published in 2020, cited by 7 articles); “Severe mitral regurgitation in nonagenarians: Impact of symptomatic status, frailty and etiology on management and outcomes” (published in 2021, cited by 5 articles); “Implementation evaluation of a medical student-led intervention to enhance students’ engagement with research: Findings and lessons learned” (published in 2021, cited by 6 articles); and “The minimally important difference predicts clinical worsening in pulmonary arterial hypertension” (published in 2023, cited by 2 articles). His scholarly contributions reflect a commitment to addressing critical clinical questions through methodologically rigorous research.

Conclusion

Dr. Arsal Hassan Ali Tharwani exemplifies the ideal blend of clinician, researcher, and leader in modern medicine. Through a strong academic foundation, robust clinical training, and dedicated research endeavors, he has built a profile distinguished by excellence and innovation. His numerous awards and publications showcase his potential to impact the fields of pulmonary and critical care medicine significantly. As he continues his fellowship training and further research, Dr. Tharwani remains committed to advancing clinical knowledge, improving patient outcomes, and contributing to the broader medical community with dedication and distinction.